Oncolytic Viruses: Therapeutics With an Identity Crisis

This publication has 41 references indexed in Scilit:

• Vaccines for established cancer: overcoming the challenges posed by immune evasion
  Nature Reviews Cancer, 2016
• Oncolytic viruses: a new class of immunotherapy drugs
  Nature Reviews Drug Discovery, 2015
• VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection
  Cancer Cell, 2015
• Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
  Nature Medicine, 2015
• STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
  Science Translational Medicine, 2015
• Going viral with cancer immunotherapy
  Nature Reviews Cancer, 2014
• The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
  Expert Review of Vaccines, 2013
• Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
  New England Journal of Medicine, 2012
• Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing
  Molecular Therapy, 2010
• Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
  Annals of Surgical Oncology, 2009